GlassScriptPhysician profile
Narin Arunakul
NPI 1659355477
$12,048.23
in general payments reported to CMS, 2019-2025
36 companies · $1,507 in 2025
The $1,507 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,971 · 2020: $1,071 · 2021: $2,026 · 2022: $1,063 · 2023: $1,609 · 2024: $1,802 · 2025: $1,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,917.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,440.49 | 2019-2025 | Jot Dx, Gallant, Aveir |
| E.R. Squibb & Sons, L.L.C. | $997.47 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $808.70 | 2019-2025 | Farxiga, Lokelma, Brilinta |
| Boston Scientific Corporation | $734.01 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Opticross |
| Janssen Pharmaceuticals, INC | $613.54 | 2019-2024 | Xarelto |
| Amgen INC. | $522.31 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $385.81 | 2019-2025 | |
| Abiomed | $335.71 | 2019-2025 | Impella |
| Philips North America LLC | $312.62 | 2019-2024 | (Ck4) Mcot |
| Pfizer INC. | $303.16 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $300.92 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.99 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $167.99 | 2022-2025 | Verquvo, Capvaxive |
| Lexicon Pharmaceuticals, INC. | $88.15 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $81.17 | 2019-2023 | Opsumit |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $73.68 | 2019 | |
| Novo Nordisk INC | $64.89 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Chiesi USA, INC. | $50.30 | 2019-2025 | Kengreal, Cleviprex |
| Bayer Healthcare Pharmaceuticals INC. | $47.77 | 2022-2025 | |
| Preventice Services, LLC | $45.89 | 2019-2021 | |
| Heartflow, INC. | $38.69 | 2022-2024 | |
| Cardiovascular Systems INC. | $34.29 | 2020-2022 | |
| United Therapeutics Corporation | $33.59 | 2019 | |
| Lilly USA, LLC | $32.58 | 2025 | Zepbound |
| Baxter Healthcare | $28.10 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Genzyme Corporation | $27.77 | 2023 | |
| Aegerion Pharmaceuticals, INC. | $26.89 | 2019 | |
| Inspire Medical Systems, INC. | $23.92 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $22.78 | 2025 | Assure Wcd |
| Daiichi Sankyo INC. | $18.71 | 2023 | Injectafer |
| Portola Pharmaceuticals, LLC | $18.32 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $18.13 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $16.70 | 2021 | |
| Vifor Pharma, INC. | $16.55 | 2019 | |
| Elutia, INC. | $15.67 | 2021 | |
| Edwards Lifesciences Corporation | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narin Arunakul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.